TERT and hepatocellular carcinoma: Among the 121 HCC cases (including recurrent tumors in a patient and multiple tumors showing a different ES grade in a patient), 37.8% (45 of 119) and 13.8% (16 of 116) harbored TERT promoter mutations and CTNNB1 mutations, respectively.